Cerene Cryotherapy Device
Channel Medsystems, Inc. · Decision date Sep 15, 2026
What did the FDA decide?
The FDA record for P180032/S024 lists the Cerene cryotherapy device, a thermal endometrial ablation device under product code MNB, with a decision of OK30 dated 2026-09-15. The supplement is a 30-Day Notice filed by Channel Medsystems, Inc. under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated change is a change in supplier of the uterine liner material. The record does not identify the prior or new supplier, the liner's material or function, or what testing supported the notice.
The S024 number ties this filing to the original PMA P180032 as a supplement, not as a new approval of the whole system. A supplier change notice is a manufacturing notification, and its reported purpose is distinct from independent proof of safety or clinical effectiveness. The record gives no clinical data, performance results, indications, or review conclusions beyond the OK30 decision code and date.
FDA approval order statement
a change in supplier of the uterine liner material
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P180032/S024
- Regulatory pathway
- PMA supplement
- Applicant
- Channel Medsystems, Inc.
- Product code
- MNB
- Decision code
- OK30
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, thermal ablation, endometrial.
- Applicant
- Channel Medsystems, Inc.
- Product code
- MNB
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P180032. Subsequent supplements may change the device or its indications.
FDA decision timeline
P180032 · Original PMA
Cerene Cryotherapy Device
P180032/S024 received
Application receipt date recorded by FDA.
P180032/S024 · FDA decision
30-Day Notice
P180032/S025 · Related supplement
Cerene Cryotherapy Device (Model number FGS-7000); Exhaust Collection Bag (Model number FGS-8000); Exhaust Collection Ba
Timeline entries are records held by MedtechLedger for P180032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P180032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cerene Cryotherapy DeviceP180032 | Channel Medsystems, Inc. | PMA approval | Mar 28, 2019 | FDA |
| Channel Medsystems, Inc. | PMA supplement | Nov 3, 2026 | FDA |
Explore the linked device profile
Other records with product code MNB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MINERVA ENDOMETRIAL ABLATION SYSTEMP140013/S019 | Axora Medical, Inc. | PMA supplement | Nov 5, 2026 | FDA |
| Axora Medical, Inc. | PMA approval | Jul 27, 2015 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Channel Medsystems, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5858 Horton St., Suite 200, Emeryville, CA, 94608
Sources and methodology
- Original FDA record: P180032/S024
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


